Total Body Irradiation
Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy
7
Low Dose Total Body Irradiation (600 cGy) as a Conditioning Regimen in Allogenic Hematopoietic Stem Cell Transplant in Children with Acute Lymphoblastic Leukemia
7
Predictive formulas expressing relationship among dose rate, duration of exposure and mortality probability in total body irradiation in humans
9
Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience
7
Predictive formulas expressing relationship between dose rate and survival time in total body irradiation in mice
12
Total body irradiation
5
Low Dose Total Body Irradiation for Relapsed Low Grade Non Hodgkin’s Lymphoma: Experience of National Cancer Institute, Cairo
10
A Clinical Dosimetry Analysis of Total Body Irradiation for Leukemia Patients
12
Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation
7
Astaxanthin attenuates total body irradiation-induced hematopoietic system injury in mice via inhibition of oxidative stress and apoptosis
14
THE EFFECTS OF TOTAL BODY IRRADIATION ON SOME ASPECTS OF HUMAN IRON METABOLISM
8
RADIATION DOSE-RATE EFFECTS ON SELECT BIOMARKERS IN A MOUSE TOTAL-BODY IRRADIATION MODEL
6
Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning
15
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society
8
Novel conditioning regimens for bone marrow transplantation
9
Canine Cyclic Neutropenia: A STEM CELL DEFECT
5
Is Use of Radiation Hormesis the Missing Link to a Better Cancer Treatment?
5
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
16
Treatment and biological dosimetry of exposed persons. Post-Chernobyl action. Final report. EUR 12558 EN. Radiation Protection Series
234
Cancer immunotherapy: are we there yet?
6